TUMOUR MARKER AND THE USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF TUMOUR DISEASES

摘要

The invention relates to the use of the type II membrane protein NP 055070 (respectively Swiss-Prot number), NHP2-type protein 1 P55769, pre-mRNA cleavage factor Im (25kD) NP008937, Lysyl-tRNA synthetase Q15046, UNR-interacting protein Q9Y3F4, nucleic transport factor 2 P13662, erythrocyte phosphatase1 isoenzyme F P24666, Prefoldin sub-unit 2 Q9UHV9, heterogeneous nuclear ribonucleoprotein C1/C2 P07910, transitional endoplasmic reticulum-ATPase P55072, bifunctional methylenetetrahydrofolic acid dehydrogenase P13995, 47 kDa heat-shock protein precursor P29043, ubiquinol-cytochrome C reductase complex core protein P31930, the fragments thereof, detector substances targeting the same, and/or nucleic acids coding for the same, for producing a means for diagnosing tumours and for the prophylactic or therapeutic treatment of tumours.